3rd Annual Gene Therapy for Ophthalmic Disorders

Paid

Revolutionizing Genetic Therapy Development & Delivery to the Eye The Race Is On; Luxturna Remains the Only Approved Gene Therapy for the Eye, Who Will Be the Next? The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting is bringing you even more world class content, bringing you two tracks of learning to tackle the pressing challenges faced i

13-16 September 2022

Healthcare

4th Annual Gene Therapy for Ophthalmic Disorders Summit

Paid

Join us at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit, where we bring together the brightest minds in biopharma and academia to revolutionize the treatment of eye diseases. This premier event is the nexus between groundbreaking preclinical research and cutting-edge clinical development, shaping the future of ophthalmology.
With

03-05 October 2023

Healthcare